Areas of Activity

Contact us

Updates

Respective efficacy of ED1000 (focused waves) and Renova (linear waves) was compared by Dr. Tsujimura, Professor, Department of Urology, Juntendo University Urayasu Hospital, Japan 

Shout out to Dr. Zoumpas on his recent and groundbreaking oral presentation at the International Society of Sexual Medicine (ISSM/SMSNA) on the subject of Female Sexual Dysfunction (FSD) treatment with MoreNova LASTwaves.

A 12 month follow-up on Female Sexual Dysfunction (FSD) by Transvaginal Shockwave Therapy (TVST) will be presented at the upcoming Scientific Meeting of World Meeting on Sexual Medicine (ISSM/SMSNA) to take place October 27-30 in Miami, FL, USA.

DirexGroup invites you to join us for interesting discussions of the latest market trends at the upcoming Congress of Japanese Men's Health on September 17-18, 2022.

A presentation of MoreNova is to take place at the upcoming Woman's Health Innovations and Inventions exhibition, July 11-12, 2022 in Tel Aviv, Israel. 

The third presentation on the latest treatment approach for Female Sexual Dysfunction (FSD), by Transvaginal Shockwave Therapy (TVST), is to be presented this week at the upcoming European Society of Sexual Medicine.

Researchers in Urology find that men infected with COVID-19 would be more likely to experience ED.

The second presentation on the latest treatment approach for Female Sexual Dysfunction and SUI, by Transvaginal Shockwave Therapy (TVST), has been accepted. 

The first of three already conducted clinical pilots, relate to using MoreNova for female Sexual Improvement and Stress Urinary Incontinence. The pilots presented at the International Continence Society (ICS) 2021 Melbourne conference.  

Vaginal treatment is the latest desirable treatment to be offered by Morenova.
Packed as a table-top, compact and lightweight device, MoreNova provides treatment for various ailments and chronic diseases long suffered by women.

Page 1 of 9

Contact Us

© 2023 DirexGroup. All Rights Reserved.